{"pageContent": "Background and purpose: Evaluate changes in bowel, urinary and sexual patient-reported quality of life following treatment with moderately hypofractionated radiotherapy (<5Gray/fraction) or stereotactic body radiation therapy (SBRT;5-10Gray/fraction) for prostate cancer.", "metaData": {"source": "Prostate cancer survivorship and psychosexual care\nhttps://pubmed.ncbi.nlm.nih.gov/25711543/"}}